Aarey Drugs & Pharmaceuticals Reports Preferential Issue Fund Utilization
Aarey Drugs & Pharmaceuticals Ltd · Others (Uncategorized) · 15 Nov 2026, 12:30 am
Aarey Drugs & Pharmaceuticals Reports Preferential Issue Fund Utilization Aarey Drugs & Pharmaceuticals reported zero deviation in the utilization of proceeds from its preferential convertible warrants issue for the quarter ended 30th Sep'26. Out of the total ₹3,190.00 Lakhs issue size (50,00,000 warrants at ₹63.80 each), the company received ₹2,481.82 Lakhs up to 30th Sep'26, which includes ₹797.50 Lakhs upon allotment on 23rd May'25 and ₹1,684.32 Lakhs from converting 35,20,000 warrants during the quarter. To date, ₹2,081.82 Lakhs has been deployed toward stated corporate objectives, with ₹400.00 Lakhs remaining unutilized in bank accounts.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- As per attachment · 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... · 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... · 14 Nov 2026
- Revised outcome · 07 Oct 2026
- Scrutinizers Report of 36th Annual General Meeting · 06 Oct 2026
